Ventricular tachycardia after initiation of fingolimod

Fingolimod, a sphingosine-1-phosphate receptor modulator, is used for the treatment of relapsing-remitting multiple sclerosis. It is well known to cause bradyarrhythmias. We present a 63-year-old woman who was admitted to the hospital with sustained monomorphic ventricular tachycardia 2 weeks after...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:BMJ Case Rep
Autors principals: Elounais, Farah, Aburahma, Ahmed, Alkotob, Mohammad Luay, Al Hadidi, Samer
Format: Artigo
Idioma:Inglês
Publicat: BMJ Publishing Group 2017
Matèries:
Unexpected Outcome (Positive or Negative) Including Adverse Drug Reactions
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5747764/
https://ncbi.nlm.nih.gov/pubmed/28954755
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bcr-2017-221819
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars